Cipla Q3 Results: Net profit jumps 48% YoY to ₹1,571 crore

Cipla, one of India's largest drugmakers by sales, reported a bigger-than-expected third-quarter profit on Tuesday, helped by ...
Cipla's oncology drug Abraxane will be launched from its Goa facility while respiratory drug Advair will be rolled out from ...
The company's consolidated net profit increased nearly 49 per cent to Rs 1,571 crore ($181.6 million) in the October-December ...
Cipla is confident of surpassing its FY25 guidance, with supply challenges for Lanreotide expected to ease by Q1FY26. The ...
Stay up-to-date with the Cipla Stock Liveblog, your comprehensive source for real-time updates and detailed analysis on a ...
Preview: India's third largest pharmaceutical company, Cipla, is scheduled to deliver its October-December quarterly earnings ...
For the first nine months of the financial year, Cipla's EBITDA margin 26.9%, which is higher than the management guidance of ...
Recent health news includes a profit boost for Swedish manufacturer Getinge, a human case of bird flu detected in the UK, and ...
Cipla, a drugmaker involved in supplying HIV medications through US-supported programmes, anticipates minimal impact from the ...